-
January 22, 2021 Daniel Carcillo’s Wesana Health Raises $4 Million to Expand Psychedelic ResearchWesana Health, founded by former NHL star Daniel Carcillo, has raised $4 million to continue...
-
January 15, 2021 Psychedelic Business News Spotlight: January 15, 2021This week in psychedelic business news, IPOs, employee stock options, mergers, research, and more.
-
January 14, 2021 Is America Ready for Psilocybin Mushroom Retreats?With Oregon's recent victory for psychedelics, psilocybin retreats could soon be commonplace. What does that...
-
January 8, 2021 Psychedelic Business News Spotlight: January 08, 2021This week in psychedelic business news, Mydecine, Neon Mind, Ehave, and more.
-
January 5, 2021 NeonMind Takes Psilocybin Therapy PublicNeonMind is the latest psychedelic company to go public. It's the first to launch on...
-
December 31, 2020 7 Psychedelic Trend Predictions for 2021The momentum for psychedelics is snowballing, and 2021 is expected to be an even bigger...
-
December 17, 2020 Psychedelic Business News Spotlight: December 17, 2020The UK gets its first psychedelic VC fund, psychedelic treatment for Parkinson's, and more business...
-
December 10, 2020 First-Ever DMT Trials for Depression Approved in UKThe UK will begin the first DMT trials for depression after Imperial College received approval...
-
December 10, 2020 Psychedelic Business News Spotlight: December 10, 2020This week in psychedelic business news: Motley Fool bets on MindMed, mushrooms go from Jamaica...
-
December 9, 2020 Psychedelic Life Science Company Cybin Acquires Ketamine Drug Maker Adelia TherapeuticsCybin Inc., has acquired the ketamine drug Spravato manufacturer Adelia Therapeutics in its first major...
